Acne vulgaris. Acne vulgaris
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients with mild to moderate acne, defined as GAGS scale, who were not satisfied with their previous acne therapies participated in the study after giving written informed consent Exclusion criteria:pregnancy or lactation; had received topical anti acne therapy two months before or during the study or any systemic therapy with antibiotics; had a skin disease that might interfere with the diagnosis or evaluation of their hyper pigmentation; were known to be allergic or sensitive to any of the study medications or their components
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Acne grading. Timepoint: Baseline and End-of-trial. Method of measurement: Global Acne Grading System(GAGS).;Acne severity. Timepoint: Baseline, the end of the first and fourth weeks, end of the study. Method of measurement: acne severity index(ASI).;Total lesion count. Timepoint: Baseline, the end of the first and fourth weeks, end of the study. Method of measurement: total lesion count( TLC). | — |
Countries
Iran (Islamic Republic of)
Contacts
Kashan University of Medical Sciences